The Epstein-Barr virus lytic cycle activator Zta interacts with methylated ZRE in the promoter of host target gene egr1

Journal of General Virology

Volumn 90, Issue 6, 2009, Pages 1450-1454

  Heather, James ^a   Flower, Kirsty ^a   Isaac, Samine ^a   Sinclair, Alison J ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; IMMEDIATE EARLY PROTEIN BZLF1; BZLF1 PROTEIN, HERPESVIRUS 4, HUMAN; DNA; EGR1 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ARTICLE; DNA RESPONSIVE ELEMENT; EPIGENETICS; EPSTEIN BARR VIRUS; GENE CONTROL; GENE TARGETING; HUMAN; METHYLATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INTERACTION; TRANSACTIVATION; VIRUS GENE; VIRUS GENOME; VIRUS REPLICATION; BINDING SITE; BIOSYNTHESIS; CELL LINE; GENETICS; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; REPORTER GENE;

HUMAN HERPESVIRUS 4;

BINDING SITES; CELL LINE; DNA; EARLY GROWTH RESPONSE PROTEIN 1; GENES, REPORTER; HERPESVIRUS 4, HUMAN; HUMANS; METHYLATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; TRANS-ACTIVATORS; VIRUS REPLICATION;

EID: 67649170780     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.007922-0     Document Type: Article

References (35)

1. Bhende, P. M., Seaman, W. T., Delecluse, H. J. & Kenney, S. C. (2004). The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome. Nat Genet 36, 1099-1104.
2. Bhende, P. M., Seaman, W. T., Delecluse, H. J. & Kenney, S. C. (2005). BZLF1 activation of the methylated form of the BRLF1 immediate-early promoter is regulated by BZLF1 residue 186. J Virol 79, 7338-7348.
3. + B cells harbor the virus in X-linked lympho-proliferative disease patients. Blood 112, 672-679.
4. Chang, Y., Lee, H. H., Chen, Y. T., Lu, J., Wu, S. Y., Chen, C. W., Takada, K. & Tsai, C. H. (2006). Induction of the early growth response 1 gene by Epstein-Barr virus lytic transactivator Zta. J Virol 80, 7748-7755.
5. Conacher, M., Callard, R., McAulay, K., Chapel, H., Webster, D., Kumararatne, D., Chandra, A., Spickett, G., Hopwood, P. A. & Crawford, D. H. (2005). Epstein-Barr virus can establish infection in the absence of a classical memory B-cell population. J Virol 79, 11128-11134.
6. Falzon, M. & Kuff, E. L. (1991). Binding of the transcription factor EBP-80 mediates the methylation response of an intracisternal A-particle long terminal repeat promoter. Mol Cell Biol 11, 117-125.
7. Feederle, R., Kost, M., Baumann, M., Janz, A., Drouet, E., Hammerschmidt, W. & Delecluse, H. J. (2000). The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J 19, 3080-3089.
8. Gutsch, D. E., Holley-Guthrie, E. A., Zhang, Q., Stein, B., Blanar, M. A., Baldwin, A. S. & Kenney, S. C. (1994). The bZIP transactivator of Epstein-Barr virus, BZLF1, functionally and physically interacts with the p65 subunit of NF-κB. Mol Cell Biol 14, 1939-1948.
9. Heston, L., El-Guindy, A., Countryman, J., Dela Cruz, C., Delecluse, H. J. & Miller, G. (2006). Amino acids in the basic domain of Epstein-Barr virus ZEBRA protein play distinct roles in DNA binding, activation of early lytic gene expression, and promotion of viral DNA replication. J Virol 80, 9115-9133.
10. Hicks, M. R., Al-Mehairi, S. S. & Sinclair, A. J. (2003). The zipper region of Epstein-Barr virus bZIP transcription factor Zta is necessary but not sufficient to direct DNA binding. J Virol 77, 8173-8177.
11. Holler, M., Westin, G., Jiricny, J. & Schaffner, W. (1988). Sp1 transcription factor binds DNA and activates transcription even when the binding site is CpG methylated. Genes Dev 2, 1127-1135.
12. Iguchi-Ariga, S. M. & Schaffner, W. (1989). CpG methylation of the cAMP-responsive enhancer/promoter sequence TGACGTCA abolishes specific factor binding as well as transcriptional activation. Genes Dev 3, 612-619.
13. Karlsson, Q. H., Schelcher, C., Verrall, E., Petosa, C. & Sinclair, A. J. (2008a). Methylated DNA recognition during the reversal of epigenetic silencing is regulated by cysteine and serine residues in the Epstein-Barr virus lytic switch protein. PLoS Pathog 4, e1000005.
14. Karlsson, Q. H., Schelcher, C., Verrall, E., Petosa, C. & Sinclair, A. J. (2008b). The reversal of epigenetic silencing of the EBV genome is regulated by viral bZIP protein. Biochem Soc Trans 36, 637-639.
15. Kouzarides, T., Packham, G., Cook, A. & Farrell, P. J. (1991). The BZLF1 protein of EBV has a coiled coil dimerization domain without a heptad leucine repeat but with homology to the C/EBP leucine zipper. Oncogene 6, 195-204.
16. Mancini, D. N., Rodenhiser, D. I., Ainsworth, P. J., O'Malley, F. P., Singh, S. M., Xing, W. & Archer, T. K. (1998). CpG methylation within the 5′ regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site. Oncogene 16, 1161-1169.
17. Miller, G. (1989). The switch between EBV latency and replication. Yale J Biol Med 62, 205-213.
18. Miller, G., El-Guindy, A., Countryman, J., Ye, J. & Gradoville, L. (2007). Lytic cycle switches of oncogenic human gammaherpesviruses. Adv Cancer Res 97, 81-109.
19. Petosa, C., Morand, P., Baudin, F., Moulin, M., Artero, J. B. & Muller, C. W. (2006). Structural basis of lytic cycle activation by the Epstein-Barr virus ZEBRA protein. Mol Cell 21, 565-572.
20. Schelcher, C., Valencia, S., Delecluse, H. J., Hicks, M. & Sinclair, A. J. (2005). Mutation of a single amino acid residue in the basic region of the Epstein-Barr virus (EBV) lytic cycle switch protein Zta (BZLF1) prevents reactivation of EBV from latency. J Virol 79, 13822-13828.
21. Schelcher, C., Al Mehairi, S., Verrall, E., Hope, Q., Flower, K., Bromley, B., Woolfson, D. N., West, M. J. & Sinclair, A. J. (2007). Atypical bZIP domain of viral transcription factor contributes to stability of dimer formation and transcriptional function. J Virol 81, 7149-7155.
22. Seyfert, V. L., McMahon, S., Glenn, W., Cao, X. M., Sukhatme, V. P. & Monroe, J. G. (1990). Egr-1 expression in surface Ig-mediated B cell activation. Kinetics and association with protein kinase C activation. J Immunol 145, 3647-3653.
23. Sinclair, A. J. (2003). bZIP proteins of human gammaherpesviruses. J Gen Virol 84, 1941-1949.
24. Sinclair, A. J. (2006). Unexpected structure of Epstein-Barr virus lytic cycle activator Zta. Trends Microbiol 14, 289-291.
25. Sinclair, A. J. & Farrell, P. J. (1992). Epstein-Barr virus transcription factors. Cell Growth Differ 3, 557-563.
26. Sista, N. D., Pagano, J. S., Liao, W. & Kenney, S. (1993). Retinoic acid is a negative regulator of the Epstein-Barr virus protein (BZLF1) that mediates disruption of latent infection. Proc Natl Acad Sci U S A 90, 3894-3898.
27. Sista, N. D., Barry, C., Sampson, K. & Pagano, J. (1995). Physical and functional interaction of the Epstein-Barr virus BZLF1 transactivator with the retinoic acid receptors RARα and RXRα. Nucleic Acids Res 23, 1729-1736.
28. Speck, S. H., Chatila, T. & Flemington, E. (1997). Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene. Trends Microbiol 5, 399-405.
29. Sukhatme, V. P., Cao, X. M., Chang, L. C., Tsai-Morris, C. H., Stamenkovich, D., Ferreira, P. C., Cohen, D. R., Edwards, S. A., Shows, T. B. & other authors (1988). A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell 53, 37-43.
30. Swenson, J. J., Holley-Guthrie, E. & Kenney, S. C. (2001). Epstein-Barr virus immediate-early protein BRLF1 interacts with CBP, promoting enhanced BRLF1 transactivation. J Virol 75, 6228-6234.
31. Thorley-Lawson, D. A., Miyashita, E. M. & Khan, G. (1996). Epstein-Barr virus and the B-cell: that's all it takes. Trends Microbiol 4, 204-208.
32. Tierney, R. J., Kirby, H. E., Nagra, J. K., Desmond, J., Bell, A. I. & Rickinson, A. B. (2000). Methylation of transcription factor binding sites in the Epstein-Barr virus latent cycle promoter Wp coincides with promoter down-regulation during virus-induced B-cell transformation. J Virol 74, 10468-10479.
33. Wang, P., Day, L., Dheekollu, J. & Lieberman, P. M. (2005). A redox-sensitive cysteine in Zta is required for Epstein-Barr virus lytic cycle DNA replication. J Virol 79, 13298-13309.
34. 1 cell cycle arrest during the Epstein-Barr virus lytic cycle. J Virol 77, 1481-1500.
35. Zhang, Q., Gutsch, D. & Kenney, S. (1994). Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency. Mol Cell Biol 14, 1929-1938.